Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.64 USD | -1.65% | +1.18% | +34.01% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.01% | 242.82Cr | |
+11.05% | 8.72TCr | |
+6.98% | 7.89TCr | |
-9.94% | 5.5TCr | |
+23.24% | 4.73TCr | |
+31.50% | 4.68TCr | |
-27.24% | 4.63TCr | |
+81.06% | 4.21TCr | |
-6.11% | 2.59TCr | |
+21.42% | 2.25TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Posts Q3 EPS $0.09, vs. Street Est of $0.05